OpenLegislation

Part 3 Transitional provision in respect of conversion of EU marketing authorisations in force immediately before IP completion dayF1

  1. 6Conversion of EU marketing authorisations in force before IP completion day
  2. 7Classification of converted EU marketing authorisations
  3. 8Obligations of licensing authority in connection with converted EU marketing authorisations
  4. 9Obligations of holders of converted EU marketing authorisations
  5. 10Powers of licensing authority in connection with provision of information
  6. 11Variations of converted EU marketing authorisations notified or applied for before IP completion day
  7. 12Variations of converted EU marketing authorisations submitted to EMA after IP completion day but before the data submission date
  8. 13Variations of converted EU marketing authorisations sought in advance of the data submission date
  9. 14Applications for renewals of converted EU marketing authorisations made before IP completion day
  10. 15Applications for renewals of conditional marketing authorisations made before IP completion day
  11. 16Applications for renewals of converted EU marketing authorisations made after IP completion day
  12. 17Applications for renewals of conditional marketing authorisations made after IP completion day
  13. 18Renewals of converted EU marketing authorisations sought in advance of the data submission date
  14. 19Article 61(3) notifications made before IP completion day in relation to converted EU marketing authorisations
  15. 20Article 61(3) notifications made in relation to converted EU marketing authorisations after IP completion day but before the data submission date
  16. 21Article 61(3) notifications sought in advance of the data submission date
  17. 22Place of establishment for converted EU marketing authorisation holder established in EEA state before IP completion day
  18. 23Temporary exemption as to packaging requirements for converted EU marketing authorisations
  19. 24Referrals made under Article 20 of Regulation (EC) No 726/2004 that have not concluded or been implemented before IP completion day
  20. 25Enforcement

Annotations

Textual amendments

F1

Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)